Subscribe Us

header ads

Recents

header ads

Medical Devices Market Size To Hit US$ 850 Billion By 2030

The global medical devices market size is expected to hit around USD 850 billion by 2030 and progressing a CAGR of 5.5% over the forecast period 2022 to 2030.

 

Medical Devices Market Size 2021 to 2030

The on medical devices Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.

Download Free Sample@ https://www.precedenceresearch.com/sample/1129

Report Scope of the Medical Devices Market

Report HighlightsDetails
Market SizeUSD 850 Billion by 2030
Growth RateCAGR of 5.5% From 2022 to 2030
Largest MarketNorth America
Base Year2021
Forecast Period2022 to 2027
Segments CoveredProduct, Therapeutic Application, End User, Region
Regional ScopeAsia Pacific, North America, Europe, Latin America, Middle East and Africa

A recent report provides crucial insights along with application based and forecast information in the Global Medical devices Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Medical devices market.

A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.

Companies and Manufacturers Covered

The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Medical devices market are included as given below:

Medical devices Market Key Players    

  • DePuy Synthes
  • Medtronics Plc
  • Fesenius Medical Care
  • GE Healthcare
  • Philips Healthcare
  • Ethicon LLC
  • Siemens Healthineers
  • Stryker
  • Cardinal Health
  • Baxter International Inc.
  • BD

Market Segments

 By Product

  • Monitoring Devices
  • Cardiac Monitoring Devices
  • Neuromonitoring Devices
  • Respiratory Monitoring Device
  • Multi-Parameter Monitoring Devices
  • Hemodynamic Monitoring Devices
  • Fetal and Neonatal Monitoring Devices
  • Temperature Monitoring Devices
  • Weight Monitoring Devices
  • Diagnostic Devices
  • Surgical ENT Devices.
  • Endoscopes
  • Imaging Devices
  • Diagnostic Molecular Devices
  • Drug Delivery Devices
  • Surgical Devices
  • Bio Implants and Stimulation Devices
  • Treatment Equipment
  • Infusion Pumps
  • Medical lasers and LASIK surgical machines
  • Others

By Therapeutic Application

  • Gastrointestinal surgery
  • General Surgery
  • Diagnostic Imaging
  • Respiratory
  • Orthopedics
  • Cardiovascular
  • Dental
  • Neurology
  • Ophthalmology
  • Ear-Nose-Throat (ENT)
  • Nephrology and Urology
  • Others

By End User

  • Hospitals & Clinics
  • Diagnostic Centers
  • Research laboratory
  • Pharmaceutical companies

By Regional Outlook

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Rest of the World

Report Objectives

  • To define, describe, and forecast the global medical devices market based on product, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
  • To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
  • To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the medical devices market

Table of Content

 Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Medical Devices Market 

5.1. COVID-19 Landscape: Medical Devices Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Medical Devices Market, By Product

8.1. Medical Devices Market, by Product Type, 2022-2030

8.1.1. Monitoring Devices

8.1.1.1. Market Revenue and Forecast (2019-2030)

8.1.2. Cardiac Monitoring Devices

8.1.2.1. Market Revenue and Forecast (2019-2030)

8.1.3. Respiratory Monitoring Device

8.1.3.1. Market Revenue and Forecast (2019-2030)

8.1.4. Multi-Parameter Monitoring Devices

8.1.4.1. Market Revenue and Forecast (2019-2030)

8.1.5. Hemodynamic Monitoring Devices

8.1.5.1. Market Revenue and Forecast (2019-2030)

8.1.6. Fetal and Neonatal Monitoring Devices

8.1.6.1. Market Revenue and Forecast (2019-2030)

8.1.7. Temperature Monitoring Devices

8.1.7.1. Market Revenue and Forecast (2019-2030)

8.1.8. Weight Monitoring Devices

8.1.8.1. Market Revenue and Forecast (2019-2030)

8.1.9. Diagnostic Devices

8.1.9.1. Market Revenue and Forecast (2019-2030)

8.1.10. Surgical ENT Devices.

8.1.10.1. Market Revenue and Forecast (2019-2030)

8.1.11. Endoscopes

8.1.11.1. Market Revenue and Forecast (2019-2030)

8.1.12. Imaging Devices

8.1.12.1. Market Revenue and Forecast (2019-2030)

8.1.13. Diagnostic Molecular Devices

8.1.13.1. Market Revenue and Forecast (2019-2030)

8.1.14. Drug Delivery Devices

8.1.14.1. Market Revenue and Forecast (2019-2030)

8.1.15. Surgical Devices

8.1.15.1. Market Revenue and Forecast (2019-2030)

8.1.16. Bio Implants and Stimulation Devices

8.1.16.1. Market Revenue and Forecast (2019-2030)

8.1.17. Treatment Equipment

8.1.17.1. Market Revenue and Forecast (2019-2030)

8.1.18. Infusion Pumps

8.1.18.1. Market Revenue and Forecast (2019-2030)

8.1.19. Medical lasers and LASIK surgical machines

8.1.19.1. Market Revenue and Forecast (2019-2030)

8.1.20. Others

8.1.20.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Medical Devices Market, By Therapeutic Application

9.1. Medical Devices Market, by Therapeutic Application, 2022-2030

9.1.1. Gastrointestinal surgery

9.1.1.1. Market Revenue and Forecast (2019-2030)

9.1.2. General Surgery

9.1.2.1. Market Revenue and Forecast (2019-2030)

9.1.3. Diagnostic Imaging

9.1.3.1. Market Revenue and Forecast (2019-2030)

9.1.4. Respiratory

9.1.4.1. Market Revenue and Forecast (2019-2030)

9.1.5. Orthopedics

9.1.5.1. Market Revenue and Forecast (2019-2030)

9.1.6. Cardiovascular

9.1.6.1. Market Revenue and Forecast (2019-2030)

9.1.7. Dental

9.1.7.1. Market Revenue and Forecast (2019-2030)

9.1.8. Neurology

9.1.8.1. Market Revenue and Forecast (2019-2030)

9.1.9. Ophthalmology

9.1.9.1. Market Revenue and Forecast (2019-2030)

9.1.10. Ear-Nose-Throat (ENT)

9.1.10.1. Market Revenue and Forecast (2019-2030)

9.1.11. Nephrology and Urology

9.1.11.1. Market Revenue and Forecast (2019-2030)

9.1.12. Others

9.1.12.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Medical Devices Market, By End User 

10.1. Medical Devices Market, by End User, 2022-2030

10.1.1. Hospitals & Clinics

10.1.1.1. Market Revenue and Forecast (2019-2030)

10.1.2. Diagnostic Centers

10.1.2.1. Market Revenue and Forecast (2019-2030)

10.1.3. Research laboratory

10.1.3.1. Market Revenue and Forecast (2019-2030)

10.1.4. Pharmaceutical Companies

10.1.4.1. Market Revenue and Forecast (2019-2030)

Chapter 11. Global Medical Devices Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product (2019-2030)

11.1.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)

11.1.3. Market Revenue and Forecast, by End User (2019-2030)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product (2019-2030)

11.1.4.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)

11.1.4.3. Market Revenue and Forecast, by End User (2019-2030)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Product (2019-2030)

11.1.5.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)

11.1.5.3. Market Revenue and Forecast, by End User (2019-2030)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product (2019-2030)

11.2.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)

11.2.3. Market Revenue and Forecast, by End User (2019-2030)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Product (2019-2030)

11.2.4.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)

11.2.4.3. Market Revenue and Forecast, by End User (2019-2030)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Product (2019-2030)

11.2.5.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)

11.2.5.3. Market Revenue and Forecast, by End User (2019-2030)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Product (2019-2030)

11.2.6.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)

11.2.6.3. Market Revenue and Forecast, by End User (2019-2030)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Product (2019-2030)

11.2.7.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)

11.2.7.3. Market Revenue and Forecast, by End User (2019-2030)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product (2019-2030)

11.3.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)

11.3.3. Market Revenue and Forecast, by End User (2019-2030)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Product (2019-2030)

11.3.4.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)

11.3.4.3. Market Revenue and Forecast, by End User (2019-2030)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Product (2019-2030)

11.3.5.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)

11.3.5.3. Market Revenue and Forecast, by End User (2019-2030)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Product (2019-2030)

11.3.6.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)

11.3.6.3. Market Revenue and Forecast, by End User (2019-2030)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Product (2019-2030)

11.3.7.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)

11.3.7.3. Market Revenue and Forecast, by End User (2019-2030)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product (2019-2030)

11.4.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)

11.4.3. Market Revenue and Forecast, by End User (2019-2030)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Product (2019-2030)

11.4.4.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)

11.4.4.3. Market Revenue and Forecast, by End User (2019-2030)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Product (2019-2030)

11.4.5.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)

11.4.5.3. Market Revenue and Forecast, by End User (2019-2030)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Product (2019-2030)

11.4.6.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)

11.4.6.3. Market Revenue and Forecast, by End User (2019-2030)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Product (2019-2030)

11.4.7.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)

11.4.7.3. Market Revenue and Forecast, by End User (2019-2030)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product (2019-2030)

11.5.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)

11.5.3. Market Revenue and Forecast, by End User (2019-2030)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Product (2019-2030)

11.5.4.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)

11.5.4.3. Market Revenue and Forecast, by End User (2019-2030)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Product (2019-2030)

11.5.5.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)

11.5.5.3. Market Revenue and Forecast, by End User (2019-2030)

Chapter 12. Company Profiles

12.1. Medtronics Plc

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Johnson & Johnson

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Fesenius Medical Care

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. DePuy Synthes

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Abbott Laboratories

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. GE Healthcare

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Philips Healthcare

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Ethicon LLC

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Siemens Healthineers AG

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Stryker

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

12.11. Cardinal Health

12.11.1. Company Overview

12.11.2. Product Offerings

12.11.3. Financial Performance

12.11.4. Recent Initiatives

12.12. Baxter International Inc.

12.12.1. Company Overview

12.12.2. Product Offerings

12.12.3. Financial Performance

12.12.4. Recent Initiatives

12.13. BD

12.13.1. Company Overview

12.13.2. Product Offerings

12.13.3. Financial Performance

12.13.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com

 

Post a Comment

0 Comments